VC
KDNY
Vivo Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-934,879
| Closed | -$35.9M | – | 55 |
|
|
2023
Q2 | $35.9M | Buy |
934,879
+62,728
| +7% | +$2.41M | 2.48% | 10 |
|
|
2023
Q1 | $20.2M | Hold |
872,151
| – | – | 1.4% | 13 |
|
|
2022
Q4 | $22.9M | Hold |
872,151
| – | – | 2.63% | 14 |
|
|
2022
Q3 | $17.1M | Hold |
872,151
| – | – | 1.89% | 16 |
|
|
2022
Q2 | $15.3M | Hold |
872,151
| – | – | 1.53% | 13 |
|
|
2022
Q1 | $14.3M | Hold |
872,151
| – | – | 0.98% | 24 |
|
|
2021
Q4 | $14.2M | Hold |
872,151
| – | – | 0.86% | 27 |
|
|
2021
Q3 | $11.1M | Hold |
872,151
| – | – | 0.5% | 34 |
|
|
2021
Q2 | $12.3M | Sell |
872,151
-334,115
| -28% | -$4.72M | 0.53% | 34 |
|
|
2021
Q1 | $18.7M | Hold |
1,206,266
| – | – | 0.66% | 31 |
|
|
2020
Q4 | $19.1M | Sell |
1,206,266
-3,912,294
| -76% | -$62M | 0.85% | 27 |
|
|
2020
Q3 | $12.4M | Hold |
5,118,560
| – | – | 0.72% | 37 |
|
|
2020
Q2 | $11.8M | Hold |
5,118,560
| – | – | 0.85% | 30 |
|
|
2020
Q1 | $14M | Buy |
+5,118,560
| New | +$14M | 1.27% | 23 |
|